MoneyWorks4Me

Lasa Supergenerics informs about outcome of board meeting

26 Aug 2022 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligation and Discourse Requirement) Regulation 2015 Lasa Supergenerics has informed that the Board of Directors at their meeting held today which commenced at 01:00 pm and concluded at 03:30 pm have considered and approved the following: The Notice of the Seventh (7th) Annual general Meeting (AGM) of the Company; The 7th AGM is scheduled to be held on Monday, September 26, 2022 at 9.30 am through Video conferencing (VC)/ Other Audio-Visual means (OAVM).

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..